|
Product
|
Antisauvagine-30
|
|
Cat#
|
34-7-12A
|
|
3-letter-code
|
DPhe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2
|
|
Sequence
|
(dF)HLLRKMIEIEKQEKEKQQAANNRLLLDTI-NH2
|
|
Unit/Weight
|
0.5mg
|
|
Unit Price
|
$195.00
|
|
MW
|
3650.3
|
|
CAS
|
220673-95-0
|
|
Formula
|
C161H274N48O46S
|
|
References
|
Brauns, O., et al., Secondary structure of antisauvagine analogues is important for CRF receptor antagonism: development of antagonists with increased potency and receptor selectivity. Peptides 23, 1817-27, (2002). Wang, L., et al., Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, 1401-10, (2001). Takahashi, L.K., et al., Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. Brain Res. 902, 135-42, (2001). Higelin, J., et al., 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors. Neuropharmacology 40, 114-22, (2001).
|
|